Effects of a bradykinin B2 receptor antagonist, FR173657, on pulmonary ischemia-reperfusion injury in dogs

Journal of Heart and Lung Transplantation

Volumn 21, Issue 9, 2002, Pages 1022-1029

  Hashimoto, Naoki ^a   Takeyoshi, Izumi ^a,c   Tsutsumi, Hirofumi ^a   Sunose, Yutaka ^a   Tokumine, Masahiko ^a   Totsuka, Osamu ^a   Ohwada, Susumu ^a   Yokoe, Takao ^a   Matsumoto, Koshi ^b   Morishita, Yasuo ^a  

^a GUNMA UNIVERSITY   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

^c GUNMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DINORTHROMBOXANE B2; 3 (6 ACETAMIDO 3 PYRIDYL) N [N [2,4 DICHLORO 3 [(2 METHYL 8 QUINOLINYL)OXYMETHYL]PHENYL] N METHYLAMINOCARBONYLMETHYL]ACRYLAMIDE; 6 OXOPROSTAGLANDIN F1 ALPHA; ICOSANOID; LEUKOTRIENE B4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL OXYGEN TENSION; ARTICLE; BRONCHUS; CONTROLLED STUDY; DOG; DRY WEIGHT; EDEMA; HEART OUTPUT; HISTOPATHOLOGY; ISCHEMIA; LUNG ALVEOLUS OXYGEN TENSION; LUNG PARENCHYMA; LUNG VASCULAR RESISTANCE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY VEIN; REPERFUSION INJURY;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DOGS; EICOSANOIDS; LUNG; LUNG DISEASES; PULMONARY CIRCULATION; PULMONARY GAS EXCHANGE; QUINOLINES; RECEPTOR, BRADYKININ B2; RECEPTORS, BRADYKININ; REPERFUSION INJURY;

EID: 0036754048     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(02)00405-9     Document Type: Article

References (31)

1. McFadden P.M., Emory W.B. Lung transplantation. Surg Clin North Am. 78:1998;749-762.
2. Kirk A.J., Colquhoun I.W., Dark J.H. Lung preservation a review of current practice and future directions . Ann Thorac Surg. 56:1993;990-1000.
3. Keck B.M., Bennett L.E., Fiol B.S., Daily O.P., Novick R.J., Hosenpud J.D. Worldwide thoracic organ transplantation a report from the UNOS/ISHLT International Registry for thoracic organ transplantation . Clin Transpl. 1996;31-45.
4. Hosenpud J.D., Bennett L.E., Keck B.M., Fiol B., Boucek M.M., Novick R.J. The Registry of the International Society for Heart and Lung Transplantation Sixteenth Official Report - 1999 . J Heart Lung Transplant. 18:1999;611-626.
5. Morganroth M.L., Till G.O., Schoeneich S., Ward P.A. Eicosanoids are involved in the permeability changes but not the pulmonary hypertension after systemic activation of complement. Lab Invest. 58:1988;316-323.
6. Cooper J.D., Pohl M.S., Patterson G.A. An update on the current status of lung transplantation report of the St. Louis International Lung Transplant Registry . Clin Transpl. 1993;95-100.
7. Theodore J., Lewiston N. Lung transplantation comes of age. N Engl J Med. 332:1990;772-774.
8. Naka Y., Roy D.K., Smerling A.J., et al. Inhaled nitric oxide fails to confer the pulmonary protection provided by distal stimulation of the nitric oxide pathway at the level of cyclic guanosine monophosphate. J Thorac Cardiovasc Surg. 110:1995;1434-1441.
9. Hamberg M., Svensson J., Samuelsson B. Novel transformation of arachidonic acid in human platelets. Proc Natl Acad Sci USA. 71:1974;3400-3404.
10. 2 . Proc Natl Acad Sci USA. 84:1987;6374-6379.
11. 2 in bovine pulmonary artery endothelial cells. Agents Actions. 40:1993;110-118.
12. 2 and C . J Biol Chem. 263:1988;14640-14647.
13. 2 receptor antagonist, FR173657. Br J Pharmacol. 120:1997;617-624.
14. Bathon J.M., Proud D. Bradykinin antagonists. Annu Rev Pharmacol Toxicol. 31:1991;129-162.
15. 1 receptors a review . Immunopharmacology. 30:1995;1-26.
16. Hoffmann T.F., Waldner H., Messmer K. The bradykinin antagonist CP-0597 can limit the progression of postischemic pancreatitis. Immunopharmacology. 33:1996;243-246.
17. Turnage R.H., Kadesky K.M., Bartula L., Myers S. Pulmonary thromboxane release following intestinal reperfusion. J Surg Res. 58:1995;552-557.
18. Bacha E.A., Herve P., Murakami S., et al. Lasting beneficial effect of short-term inhaled nitric oxide on graft function after lung transplantation. J Thorac Cardiovasc Surg. 112:1996;590-598.
19. Naka Y., Roy D.K., Liao H., et al. cAMP-mediated vascular protection in an orthotopic rat lung transplant model. Circ Res. 79:1996;773-783.
20. Bhabra M.S., Hopkinson D.N., Shaw T.E., Hooper T.L. Relative importance of prostaglandin/cyclic adenosine monophosphate and nitric oxide/cyclic guanosine monophosphate pathways in lung preservation. Ann Thorac Surg. 62:1996;1494-1499.
21. Simon L.S. Role and regulation of cyclooxygenase-2 during inflammation. Am J Med. 106:(suppl):1999;37S-42S.
22. Kaplan E., Diehl J.T., Peterson M.B., et al. Extended ex vivo preservation of the heart and lungs. Effects of acellular oxygen-carrying perfusates and indomethacin on the autoperfused working heart-lung preparation. J Thorac Cardiovasc Surg. 100:1990;687-698.
23. 2 synthetase inhibitor against ischemic liver injury. Surg Today. 24:1994;435-440.
24. Lehr H.A., Guhlmann A., Nolte D., Keppler D., Messmer K. Leukotrienes as mediators in ischemia-reperfusion injury in a microcirculation model in the hamster. J Clin Invest. 87:1991;2036-2041.
25. 2 receptor antagonist, FR173657, on plasma exudation in rat carrageenin-induced pleurisy. Br J Pharmacol. 121:1997;723-730.
26. 2 receptor antagonist FR173657 inhibition of effects of bradykinin related to its role in nociception . Br J Pharmacol. 124:1998;1328-1334.
27. 2 receptor antagonists. Br J Pharmacol. 126:1999;197-204.
28. 2 receptor antagonist, FR173657, on plasma extravasation in guinea pig airways. Eur J Pharmacol. 367:1999;373-378.
29. 2 receptor antagonists in human and rat urinary bladder. Eur J Pharmacol. 388:2000;177-182.
30. 2 moderates permeability after limb ischemia. Ann Surg. 202:1985;624-626.
31. Linz W., Wiemer G., Schölkens B.A. ACE-inhibition induces NO-formation in cultured bovine endothelial cells and protects isolated ischemic rat hearts. J Mol Cell Cardiol. 24:1992;909-919.